Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Coral Gables, FL
SEC filing record 1 source field available
Fiscal year end
31 December
RELMADA THERAPEUTICS, INC. has filed 598 SEC EDGAR filings since 13 Nov 2012

SEC filing history

Showing 301-325 of 598 matching filings.

Per page
25
Current page
13
8-K File 001-39082

CURRENT REPORT

Filing date
07 Jan 2021
Reporting date
06 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39082

FORM 8-K

Filing date
05 Jan 2021
Reporting date
31 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Jan 2021
Reporting date
04 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39082

CURRENT REPORT

Filing date
14 Dec 2020
Reporting date
14 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39082

CURRENT REPORT

Filing date
08 Dec 2020
Reporting date
07 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Dec 2020
Reporting date
24 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39082

CURRENT REPORT

Filing date
16 Nov 2020
Reporting date
16 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-39082

QUARTERLY REPORT

Filing date
12 Nov 2020
Reporting date
30 Sep 2020
Next action
Verify source filing
4

4 filing

Filing date
03 Nov 2020
Reporting date
02 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39082

CURRENT REPORT

Filing date
27 Oct 2020
Reporting date
27 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Oct 2020
Reporting date
01 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Sep 2020
Reporting date
01 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-245054

EFFECT filing

Filing date
21 Aug 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
19 Aug 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
19 Aug 2020
Reporting date
18 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
19 Aug 2020
Reporting date
18 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 Aug 2020
Reporting date
18 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
18 Aug 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-245054

REGISTRATION STATEMENT

Filing date
12 Aug 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-39082

QUARTERLY REPORT

Filing date
12 Aug 2020
Reporting date
30 Jun 2020
Next action
Verify source filing
4

4 filing

Filing date
04 Aug 2020
Reporting date
03 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Jul 2020
Reporting date
01 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88207

13G

Filing date
11 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39082

CURRENT REPORT

Filing date
03 Jun 2020
Reporting date
02 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-234262

PROSPECTUS SUPPLEMENT

Filing date
15 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .